CD14 and B-cell chronic lymphocytic leukemia: In addition, a monocytic subset of MDSC (CD14+HLA-DRlow) is increased in CLL (chronic lymphocytic leukaemia) patients and has a capacity to inhibit T cell activation, as well as induce Treg via IDO [18].